NIREUSAQUACULTURES.A. Mainevents12M2013 - - PowerPoint PPT Presentation

nireus aquaculture s a main events 12m 2013
SMART_READER_LITE
LIVE PREVIEW

NIREUSAQUACULTURES.A. Mainevents12M2013 - - PowerPoint PPT Presentation

AthensGreece|31March2014 12Months2013ResultsPresentation NIREUSAQUACULTURES.A. Mainevents12M2013


slide-1
SLIDE 1

12Months2013ResultsPresentation

NIREUSAQUACULTURES.A.

AthensGreece|31March2014

slide-2
SLIDE 2

2

  • !"#$ %
  • &'(
  • )(** $ '$
  • € 30mi.fromlowerfishsalesprices– fromwhich€ 10mi.correspondto

lowerfishsalesvalue&€ 20mi.tolowervaluationofbiomass

  • € 3mi.fromhigheraveragerawmaterialpricesforfishfeed
  • € 24mi.fromlowerthanexpectedgrowthofthebiologicalassets
  • € 11.3 mi.one offprovisionsoffromwhich€ 6.4foraffiliates chargedto

financialexpensesand€ 4.9mi.forcustomers

  • additionaldeferredtaxes€ 2.7mi.fromtheincreaseofthecorporatetax

rateto26%

Mainevents12M2013

Keypoints

slide-3
SLIDE 3

3

Bass&bream– ExportpricetoItaly&Spain

Source:Kontalianalyse“Seabass&SeabreamFeb2014monthlyreport”

  • ExternalFactors
slide-4
SLIDE 4

4

Industrysupplydevelopment

Externalfactors

Theexpectedproductionof seabassandseabreamin 2013,versus2012,was:

  • atslightlyhigherlevels
  • withdeclininggrowth

Pricesweremostlyaffected bytheliquidityneedsofthe sector

slide-5
SLIDE 5

5

SalesbyBusinessSector

! + ",-"% . /+ 001&/2 3

Salesoffishfarmingdown € 6.1mi.fromdeclineinaverageweightedprice&reduced juvenilessales– fishvolumesup+4% Feedsalesup+€ 3.4mi. Salesofaviculture,animalcultureproducts&equipmentdown€ 0.9mi Salesevolution Salesbysectorfor12M2013 (%distribution)

slide-6
SLIDE 6

6

ExportsEvolution

Salesevolution

in€ 45404 4540% Greece 46.57 44.38 EU 122.24 122.26 Other 33.34 31.95

  • Εxports

Domesticsales

Exports&domesticsalesdistribution(%)

Exportsshareto78%oftotalsales

slide-7
SLIDE 7

7

BalanceSheet

Financials Endofperiod biologicalassets valuelower€ 70mi. from:

  • lowerfishprices
  • lowerthan

expectedgrowth

Assets

inmi.€

12M2013 12M2012 66&3 7# 7

  • %07((

%07(( 8$ (070 *%7( /$ 7# *7( TotalnonCcurrent 204,23 189,50 8 0070 74 9 07(# 7% : #7% *#7 / #7( 447% ;23 7# (7 Totalcurrent 184,50 280,91 Totalassets 388,73 470,40

Equityandliabilities

inmi.€

12M2013 12M2012 <=3 #7* #47( )$

  • 70.
  • *740.
  • Totalshareholders'equity

andnonCcontrolling interests 57,69 137,67 >?@ %7%0 *7% A ' *7(% 70# /$ 47*% 7*# TotalnonCcurrentliabilities 56,57 112,97 2 74% 47*# ;@ %7*# %74 / 7(0 *7 Totalcurrentliabilities 274,48 219,76 Totalliabilities 331,05 332,74 Totalequityandliabilities 388,73 470,40

slide-8
SLIDE 8

8

IncomeStatement

Netresultsimpactedby:

  • € 30from lowerpricing
  • € 24 mi.fromlowerthan

expectedbiomassgrowth

  • € 3mi.fromhigherraw

materialscostforfishfeed

  • OneCoffprovisionsof€ 11.3

mi.fromwhich€ 6.4mi.for affiliatesand€ 4.9mi.for customers

  • € 2.7additionaldeferredtax

fromtheincreaseofcorporate taxrate Financials

  • 12M2013

12M2012 8< 149,47 158,92 )$8< 49,11 43,24 TotalSales 198,58 202,16 Effectofmeasurementofbiological assetsatfairvalue(*) (71,27)

  • (11,51)
  • :
  • 0(7#%.
  • 0#7.
  • <2'
  • %07*.
  • %7*4.
  • %
  • 7.
  • 4#7#0.
  • /'
  • %74.
  • 470.
  • /

474

  • %70
  • EBITDAbeforebiologicaladjustment

(13,80)

  • 20,99
  • 8,
  • #7%.
  • #74(.
  • EBITDAafterbiologicaladjustment

(60,17)

  • 6,73
  • Earnings/(loss)beforeinterest

andtaxes(EBIT) (67,74)

  • (2,24)
  • Earnings/(loss)beforetaxes(EBT)

(87,43)

  • (16,17)
  • '

7*

  • 474(
  • Earnings/(loss)aftertaxes(EAT)

(75,48)

  • (13,89)
  • &3
  • (*70(.
  • #70*.
  • )$
  • 07#.
  • 07
  • &-.
  • 7(.
  • 07440.
  • B.3-"$.

?- .9!:<

slide-9
SLIDE 9

9

CashFlowStatement

Financials

PositiveCFO€ 7.19 mi. Increasednetinvestments

  • Newpackagingplantin

WesternGreecetargetingcost reduction

  • 12M2013

12M2012 6 '

  • (7#%.
  • 7(.
  • A

74

  • 7(%
  • 5

4#7%

  • #7%
  • !,

#7%(

  • #74*
  • :?-.

447*

  • 7#0.
  • :?-.
  • 4744.
  • %7.
  • :.? 2
  • 470#
  • 70#
  • 9'
  • 7#4.
  • %7(#.
  • '
  • 074#.
  • 07((.
  • Cashflowfromoperatingactivities

7,19

  • 14,16
  • )-9.?A
  • 7*.
  • *7*.
  • FCFFreecashflowafteroperations

andinvestments 0,33

  • 8,60
  • :

0740

  • 07%#
  • Cashflowfrominvestingactivities

(6,66)

  • (5,22)
  • Cashflowfromfinancingactivities

1,22

  • (14,08)
  • Totalcashflowreportingperiod

1,75

  • (5,15)
  • ;3

%70

  • 7
  • !',
  • 7#.
  • 070#
  • Cashandcashequivalentsatthe

endoftheperiod 3,62

  • 3,01
slide-10
SLIDE 10

10

  • FeedConsumptionandJuvenilesInput

Outlook

slide-11
SLIDE 11

11

Bass&bream– Weeklypricedevelopment2014

Source:Kontalianalyse“Seabass&SeabreamFeb2014monthlyreport” Mercamadridpricesarewholesaleandindicativeofthepricetrend– actualfishpricesvarybysizeandmarket

  • ExternalFactors
slide-12
SLIDE 12

12

Appendix:Costdynamicsinfishfarming

HarvestWeight

NormalOperations Operations+Disease+Mortality Operations+Disease

Costperkg

cost Mortality cost Disease cost Weight

C@ disease 0$,$ mortality

Appendix

slide-13
SLIDE 13

13

Appendix:IAS41forbiologicalassets

! 3 $ , -9!:<%2 9D<#.

  • @.

'@ , @ @ $ $ 8< $ <9<$ 8 , -. )$ ?,7 737

  • .7

E biomassatbeginningofperiod (+)purchasesofbiologicalassetsforproduction ( )biomassatendofperiod =effectofmeasurementofbiomassatfairvalue

Fairvalueof biomass(B.S.)

VolumexPrice

KeyDrivers

MVolume M Price

BiologicalSales (I.S.)

Thesalesoffish& juvenilesproduced– to includeprocessedfish

NonCbiological sales(I.S.)

Thesalesoffish& juvenilesproducedby

  • thers,fishfeed,nets,
  • therproducts

TotalSales (I.S.)

Biologicalsales+ NonCbiologicalsales

Effectof measurement

  • fbiomassat

fairvalue

TheinterCperiod differenceinthefair biomassvalue Appendix

slide-14
SLIDE 14

14

Communication– FinancialCalendar

InvestorRelations

Ms.MariaKotsovou,IRManager "%040%%* 5"%0%%%* &@F

FinancialCalendar2014

12M2013Results Monday,31March2014 %540#:E !7%0540# /D5E 57%0G40# 540#:E !74D40# 540#:E !74)40#

Legal Notice

This presentation has been prepared solely for informational purposes. Any projections or other estimates in this presentation, including estimates of returns or performance, comments with respect to our objectives and strategies, or the results

  • f our operations and business, are forwardClooking statements based upon certain

assumptions that may be wrong. These assumptions may be influenced by factors within or beyond our control, and actual results may differ materially from any estimates and projections. Factors influencing actual results include but are not limited to fluctuations in fish prices and raw material prices, the effects

  • f

competition in the areas in which we operate, changes in the economic environment, regulatory and economic conditions. This presentation is not an offer to buy or sell

  • r a solicitation of an offer to buy or sell any security or instrument or to participate

in any trading strategy. No part

  • f

this presentation may be construed as constituting investment advice or a recommendation to enter into any transaction. No representation or warranty is given with respect to the accuracy or completeness

  • f the information contained in this presentation, and no claim is made that any

future offer to transact any securities will conform to any terms that may be contained herein. Before entering into any transaction, investors should determine any economic risks and benefits, as well as any legal, tax and accounting consequences of doing so, as well as their ability to assume such risks, without reliance on the information contained in this presentation.

Appendix